BANB:SWX
BACHEM HOLDING AG
CHF 79.55
arrow_downward
-1.30%(-1.05) 1D
Nov 13, 5:30:00 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BANB...
Open
CHF 80.65
High
CHF 80.90
Low
CHF 79.35
Mkt. cap
5.97B
Avg. vol.
81.54K
Volume
51.89K
Dividend
1.13%
Quarterly dividend
CHF 0.22
Ex-dividend date
May 4, 2026
P/E ratio
40.11
52-wk high
CHF 86.00
52-wk low
CHF 48.52
EPS
CHF 1.98
Shares outstanding
75.00M
No. of employees
3K
Open
CHF 80.65
High
CHF 80.90
Low
CHF 79.35
Mkt. cap
5.97B
Avg. vol.
81.54K
Volume
51.89K
Dividend
1.13%
Quarterly dividend
CHF 0.22
Ex-dividend date
May 4, 2026
P/E ratio
40.11
52-wk high
CHF 86.00
52-wk low
CHF 48.52
EPS
CHF 1.98
Shares outstanding
75.00M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Nasdaq
·
1 day ago
Chartstopper: November 13, 2026
Bloomberg.com
·
18 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients. The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.
The head office is in Bubendorf in the canton of Basel-Landschaft. Bachem operates production facilities in Vionnaz, Vista and Torrance, and St Helens, as well as a sales and distribution site in Tokyo.
Bachem is one of the largest manufacturers of peptide-based APIs globally, supplying pharmaceutical and biotechnology companies with products used in both clinical development and commercial therapies.
In recent years, the company has expanded its manufacturing capacity, including new large-scale production facilities in Switzerland and the United States.
At the end of 2025, the company employed 2,511 people, reported revenue of CHF 695.1 million, and net income of CHF 148.8 million. Wikipedia
About BACHEM HOLDING AG